Unknown PHASE4 INTERVENTIONAL NCT00288548

Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Effects of the Combination of Metoprolol and Formoterol in COPD

Sponsor: Martini Hospital Groningen

Conditions Chronic Obstructive Pulmonary Disease (COPD)

Interventions Metoprolol

Updated 5 times since 2017 Last updated: Feb 17, 2006 Started: Feb 28, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00288548, this PHASE4 trial focuses on Chronic Obstructive Pulmonary Disease (COPD) and remains ongoing. Sponsored by Martini Hospital Groningen, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Feb 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Martini Hospital Groningen

Data source: Martini Hospital Groningen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Groningen, Netherlands